Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.
Hampton, Virginia, United States Related Funds
| Fund Name | Location |
| Atlantic Innovation Fund | - |
| Core Associates | Florida, Jupiter, United States |
| Lacuna LLC | Boulder, Colorado, United States |
| Penghua Fund | China, Guangdong, Shenzhen |
| QinetiQ | Cardigan, Ceredigion, United Kingdom |
| RyderVentures | Florida, Miami, United States |
| Suhehui | China, Shanghai |
| SVG Media | Gurgaon, Haryana, India |
| Uchida Yoko | Japan, Tokyo |
| Wardenclyffe Partners | Delaware, Dover, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Vizgen | $85M | 03 Jun 2022 | Cambridge, Massachusetts, United States | ||
Sherlock Biosciences | $80M | 08 Mar 2022 | Cambridge, Massachusetts, United States | ||
Ori Biotech | $100M | 18 Jan 2022 | London, England, United Kingdom | ||
SkylineDx | 21 Dec 2021 | Rotterdam, South Holland, Netherlands | |||
AgBiome | $116M | 14 Sep 2021 | Raleigh, North Carolina, United States | ||
Modality.AI, Inc | $2M | 30 Jul 2021 | San Francisco, California, United States | ||
Vizgen | $37M | 07 Apr 2021 | Cambridge, Massachusetts, United States | ||
Cerevel Therapeutics | $320M | 29 Jul 2020 | Boston, Massachusetts, United States | ||
Enko Chem | $45M | 26 Jun 2020 | Woburn, Massachusetts, United States |
– AgBiome raised $116m in an oversubscribed Series D round of funding.
– The round was co-led by Blue Horizon and Novalis LifeSciences and included multiple new and existing investors.
– The company will use the capital to expand more rapidly its product portfolio, scale its scientific and commercial teams, and continue to build its global presence and partnerships.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 
Get matched with relevant funds
